Swiss National Bank
GRNA

Swiss National Bank’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Swiss National Bank’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-182,925
Closed -$216K – 2683
2022
Q4 		$216K Buy
182,925
+67,100
+58% +$109K ﹤0.01% 2667
2022
Q3 		$269K Hold
115,825
– – ﹤0.01% 2672
2022
Q2 		$256K Buy
+115,825
New +$803K ﹤0.01% 2721

Other funds holding GRNA

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CGC
Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

Swiss National Bank's GRNA Position: Q1 2023 in Review

Swiss National Bank sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q1 2023, closing a stake of 182,925 shares — an estimated $216K sold.

Swiss National Bank first reported a position in GRNA in Q2 2022 and held it in 3 quarters. The position peaked at $269K in Q3 2022. 60 funds tracked by Wall St. Rank hold GRNA as of Q1 2023.

  • Swiss National Bank reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q1 2023 after selling out during the quarter.
  • Swiss National Bank sold 182,925 GreenLight Biosciences Holdings, PBC Common Stock shares in Q1 2023, an estimated $216K.
  • Swiss National Bank first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2022 and held it in 3 quarters.
  • Swiss National Bank's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $269K in Q3 2022.
  • 60 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q1 2023.

Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.